Aurora Innovation, Inc. Warrant (AUROW) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AUROW SEC filings page.
Aurora Innovation, Inc. Warrant (AUROW) reported $3.0M in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
AUROW is funding a development-stage cost base through financing while reported commercial revenue remains minimal.
In FY2025, operating cash flow of-$581M and free cash flow of-$612M were paired with financing cash flow of$834M . That combination indicates reported cash demands were being met primarily through financing rather than internally generated cash.
The latest operating profile is dominated by research and development investment:
The balance sheet is relatively lightly burdened by liabilities: FY2025 liabilities were
Financial Health Signals
Aurora Innovation, Inc. Warrant does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Aurora Innovation, Inc. Warrant passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.
Aurora Innovation, Inc. Warrant reported a net loss of $816.0M while operations used $581.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Aurora Innovation, Inc. Warrant generated $2.0M in revenue in Q2 2026. This represents an increase of 100.0% from the same quarter a year earlier. Against the prior quarter it is up 100.0%.
Aurora Innovation, Inc. Warrant's EBITDA was -$260.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Aurora Innovation, Inc. Warrant reported a net loss of $270.0M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Aurora Innovation, Inc. Warrant earned -$0.14 per diluted share (EPS) in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Aurora Innovation, Inc. Warrant recorded an outflow of $256.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Aurora Innovation, Inc. Warrant held $136.0M in cash as of Q2 2026; no long-term debt figure is on record for that period.
Not reported for Q2 2026.
Margins & Returns
Aurora Innovation, Inc. Warrant's quarterly ROE was -13.8% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 3.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.5 percentage points.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Aurora Innovation, Inc. Warrant invested $211.0M in research and development in Q2 2026. This represents an increase of 11.1% from the same quarter a year earlier. Against the prior quarter it is up 8.2%.
Aurora Innovation, Inc. Warrant invested $31.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 342.9% from the same quarter a year earlier. Against the prior quarter it is up 24.0%.
Not reported for Q2 2026.
AUROW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M+100.0% | $1.0Mn/m | N/A | $1.0Mn/m | $1.0Mn/m | $0 | N/A | $0 |
| Cost of Revenue | $7.0M+40.0% | $6.0Mn/m | N/A | $6.0Mn/m | $5.0Mn/m | $0 | N/A | $0 |
| Gross Profit | -$5.0Mn/m | -$5.0Mn/m | N/A | -$5.0Mn/m | -$4.0Mn/m | $0 | N/A | $0 |
| R&D Expenses | $211.0M+11.1% | $195.0M+7.1% | N/A | $179.0M+5.9% | $190.0M+11.8% | $182.0M+9.6% | N/A | $169.0M-7.1% |
| SG&A Expenses | $50.0M+38.9% | $44.0M+51.7% | N/A | $38.0M+40.7% | $36.0M+28.6% | $29.0M+7.4% | N/A | $27.0M-10.0% |
| Operating Income | -$266.0Mn/m | -$244.0Mn/m | N/A | -$222.0Mn/m | -$230.0Mn/m | -$211.0Mn/m | N/A | -$196.0Mn/m |
| EBITDA | -$260.0Mn/m | -$238.0Mn/m | N/A | -$216.0Mn/m | -$225.0Mn/m | -$205.0Mn/m | N/A | -$192.0Mn/m |
| Income Tax | $0n/m | $0n/m | N/A | $0n/m | $0n/m | $0n/m | N/A | $0n/m |
| Net Income | -$270.0Mn/m | -$223.0Mn/m | N/A | -$201.0Mn/m | -$201.0Mn/m | -$208.0Mn/m | N/A | -$208.0Mn/m |
| EPS (Basic) | -$0.14n/m | -$0.11n/m | -$0.10n/m | -$0.11n/m | -$0.11n/m | -$0.12n/m | -$0.11n/m | -$0.13n/m |
| EPS (Diluted) | -$0.14n/m | -$0.11n/m | -$0.10n/m | -$0.11n/m | -$0.11n/m | -$0.12n/m | -$0.11n/m | -$0.13n/m |
| Diluted Shares (Avg) | 1.98B+10.7% | 1.95B+11.7% | N/A | 1.89B+14.1% | 1.78B+14.9% | 1.74B+13.5% | N/A | 1.66B+15.7% |
Not reported in any period shown, so not listed: Interest Expense.
AUROW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.2B-2.1% | $2.2B+5.5% | $2.3B+9.6% | $2.5B+10.8% | $2.2B+15.7% | $2.1B-0.9% | $2.1B-4.3% | $2.3B-3.8% |
| Current Assets | $1.3B-6.6% | $1.3B+6.6% | $1.3B+5.0% | $1.3B+0.7% | $1.3B+28.5% | $1.2B+4.5% | $1.3B+3.0% | $1.3B-14.0% |
| Cash & Equivalents | $136.0M-34.0% | $273.0M+60.6% | $221.0M+4.7% | $87.0M-66.9% | $206.0M-48.8% | $170.0M-62.6% | $211.0M-57.9% | $263.0M-72.4% |
| Short-Term Investments | $1.1B-2.0% | $952.0M-3.7% | $1.1B+4.2% | $1.2B+17.8% | $1.1B+78.5% | $989.0M+49.4% | $1.0B+44.8% | $985.0M+90.2% |
| Long-Term Investments | $0n/m | $52.0Mn/m | $183.0Mn/m | $357.0M+243.3% | $0n/m | $0-100.0% | $0-100.0% | $104.0Mn/m |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | $0n/m | N/A |
| Total Liabilities | $214.0M-4.0% | $221.0M-22.7% | $203.0M-22.8% | $219.0M-11.3% | $223.0M+13.2% | $286.0M+23.8% | $263.0M+5.2% | $247.0M+12.3% |
| Current Liabilities | $110.0M+39.2% | $134.0M+7.2% | $111.0M+5.7% | $84.0M-9.7% | $79.0M-2.5% | $125.0M+13.6% | $105.0M-5.4% | $93.0M+2.2% |
| Non-Current Liabilities | $104.0M-27.8% | $87.0M-46.0% | $92.0M-41.8% | $135.0M-12.3% | $144.0M+24.1% | $161.0M+33.1% | $158.0M+13.7% | $154.0M+19.4% |
| Total Equity | $2.0B-1.9% | $2.0B+10.0% | $2.1B+14.1% | $2.3B+13.5% | $2.0B+16.0% | $1.8B-3.9% | $1.9B-5.5% | $2.0B-5.4% |
| Retained Earnings | -$5.7Bn/m | -$5.4Bn/m | -$5.2Bn/m | -$5.0Bn/m | -$4.8Bn/m | -$4.6Bn/m | -$4.4Bn/m | -$4.2Bn/m |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Long-Term Debt.
AUROW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$225.0Mn/m | -$159.0Mn/m | -$146.0Mn/m | -$149.0Mn/m | -$144.0Mn/m | -$142.0Mn/m | -$142.0Mn/m | -$143.0Mn/m |
| Depreciation & Amortization | $6.0M+20.0% | $6.0M0.0% | $13.0M+116.7% | $6.0M+50.0% | $5.0M-16.7% | $6.0M+20.0% | $6.0M0.0% | $4.0M-20.0% |
| Stock-Based Compensation | $60.0M+9.1% | $46.0M+35.3% | N/A | $51.0M+45.7% | $55.0M+44.7% | $34.0M-5.6% | N/A | $35.0M-14.6% |
| Capital Expenditures | $31.0M+342.9% | $25.0M+212.5% | $8.0M0.0% | $8.0M+14.3% | $7.0M-36.4% | $8.0M0.0% | $8.0M+100.0% | $7.0M+40.0% |
| Free Cash Flow | -$256.0Mn/m | -$184.0Mn/m | -$154.0Mn/m | -$157.0Mn/m | -$151.0Mn/m | -$150.0Mn/m | -$150.0Mn/m | -$150.0Mn/m |
| Investing Cash Flow | -$109.0Mn/m | $209.0M+1000.0% | $273.0M+274.0% | -$419.0Mn/m | -$118.0M-198.3% | $19.0M-81.2% | $73.0Mn/m | -$466.0M-548.1% |
| Financing Cash Flow | $199.0M-33.2% | $4.0M-95.1% | $6.0M-64.7% | $448.0M-4.5% | $298.0M+7350.0% | $82.0M+4000.0% | $17.0M+325.0% | $469.0M-43.6% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
AUROW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -250.0% | -500.0% | N/A | -500.0% | -400.0% | N/A | N/A | N/A |
| Operating Margin | -13300.0% | -24400.0% | N/A | -22200.0% | -23000.0% | N/A | N/A | N/A |
| Net Margin | -13500.0% | -22300.0% | N/A | -20100.0% | -20100.0% | N/A | N/A | N/A |
| Return on Equity | -13.8%-3.7pp | -11.3%+0.3pp | N/A | -8.8%+1.5pp | -10.1%+0.5pp | -11.7%-2.8pp | N/A | -10.3%-1.4pp |
| Return on Assets | -12.5%-3.4pp | -10.2%-0.2pp | N/A | -8.0%+1.2pp | -9.1%+0.4pp | -10.0%-2.1pp | N/A | -9.2%-1.1pp |
| Current Ratio | 11.38-5.6x | 9.49-0.1x | 11.86-0.1x | 15.29+1.6x | 16.96+4.1x | 9.54-0.8x | 11.94+1.0x | 13.71-2.6x |
| Liabilities-to-Equity | 0.110.0x | 0.110.0x | 0.090.0x | 0.100.0x | 0.110.0x | 0.160.0x | 0.140.0x | 0.120.0x |
| Asset Turnover | 0.000.0x | 0.000.0x | N/A | 0.000.0x | 0.000.0x | 0.00 | N/A | 0.00 |
| FCF Margin | -12800.0% | -18400.0% | N/A | -15700.0% | -15100.0% | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Where Aurora Innovation, Inc. Warrant Ranks
Frequently Asked Questions
What is Aurora Innovation, Inc. Warrant's annual revenue?
Aurora Innovation, Inc. Warrant (AUROW) reported $3.0M in total revenue for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Aurora Innovation, Inc. Warrant profitable?
No, Aurora Innovation, Inc. Warrant (AUROW) reported a net loss of $816.0M in fiscal year 2025.
What is Aurora Innovation, Inc. Warrant's EBITDA?
Aurora Innovation, Inc. Warrant (AUROW) had EBITDA of -$871.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Aurora Innovation, Inc. Warrant's return on equity (ROE)?
Aurora Innovation, Inc. Warrant (AUROW) has a return on equity of -38.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Aurora Innovation, Inc. Warrant's free cash flow?
Aurora Innovation, Inc. Warrant (AUROW) recorded an outflow of $612.0M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Aurora Innovation, Inc. Warrant's operating cash flow?
Aurora Innovation, Inc. Warrant (AUROW) recorded an outflow of $581.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Aurora Innovation, Inc. Warrant's total assets?
Aurora Innovation, Inc. Warrant (AUROW) had $2.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Aurora Innovation, Inc. Warrant's capital expenditures?
Aurora Innovation, Inc. Warrant (AUROW) invested $31.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Aurora Innovation, Inc. Warrant spend on research and development?
Aurora Innovation, Inc. Warrant (AUROW) invested $745.0M in research and development during fiscal year 2025.
What is Aurora Innovation, Inc. Warrant's current ratio?
Aurora Innovation, Inc. Warrant (AUROW) had a current ratio of 11.86 as of fiscal year 2025, which is generally considered healthy.
What is Aurora Innovation, Inc. Warrant's liabilities-to-equity ratio?
Aurora Innovation, Inc. Warrant (AUROW) had a liabilities-to-equity ratio of 0.09 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
What is Aurora Innovation, Inc. Warrant's return on assets (ROA)?
Aurora Innovation, Inc. Warrant (AUROW) had a return on assets of -34.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does Aurora Innovation, Inc. Warrant's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Aurora Innovation, Inc. Warrant (AUROW) held $1.5B in cash, cash equivalents and investments, and reported an operating cash outflow of $581.0M over that year. Dividing the one by the other, the reported balance equals about 30 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Aurora Innovation, Inc. Warrant's Piotroski F-Score?
Aurora Innovation, Inc. Warrant (AUROW) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Aurora Innovation, Inc. Warrant's earnings high quality?
Aurora Innovation, Inc. Warrant (AUROW) reported a net loss of $816.0M while operations used $581.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.